New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The deal signals a clear push to expand access to care in underserved regions
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Aims to boost speed & precision in patient care
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals)_256_384.jpg)
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Subscribe To Our Newsletter & Stay Updated
